Price tag on gene therapy for rare form of blindness: $850K


WASHINGTON -- A first-of-its kind genetic treatment for blindness will cost $850,000 per patient, making it one of the most expensive medicines in the world and raising questions about the affordability of a coming wave of similar gene-targeting therapies.

This story is only available from our archives.

Log in to comment